Your browser doesn't support javascript.
loading
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study.
Dikmen, H O; Yilmaz, K; Benoit, S; Bernard, P; Drenovska, K; Gerdes, S; Gläser, R; Günther, C; Homey, B; Horváth, O N; Huilaja, L; Joly, P; Kiritsi, D; Meller, S; Patsatsi, A; Sárdy, M; Schauer, F; Shahid, M; Sticherling, M; Tasanen, K; Vassileva, S; Worm, M; Zillikens, D; Sadik, C D; van Beek, N; König, I R; Schmidt, E.
Afiliación
  • Dikmen HO; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Yilmaz K; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Benoit S; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
  • Bernard P; Department of Dermatology, University of Reims, Reims, France.
  • Drenovska K; Department of Dermatology, Medical University Sofia, Sofia, Bulgaria.
  • Gerdes S; Department of Dermatology, Venerology and Allergology, University of Kiel, Kiel, Germany.
  • Gläser R; Department of Dermatology, Venerology and Allergology, University of Kiel, Kiel, Germany.
  • Günther C; Department of Dermatology, University of Dresden, Dresden, Germany.
  • Homey B; Department of Dermatology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.
  • Horváth ON; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Huilaja L; PEDEGO Research Unit, Department of Dermatology, Medical Research Unit, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Joly P; Department of Dermatology, University of Rouen, Rouen, France.
  • Kiritsi D; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Meller S; Department of Dermatology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.
  • Patsatsi A; 2nd Dermatology Department, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece.
  • Sárdy M; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Schauer F; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
  • Shahid M; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Sticherling M; Department of Dermatology, Medical University Sofia, Sofia, Bulgaria.
  • Tasanen K; Department of Dermatology, University of Erlangen, Erlangen, Germany.
  • Vassileva S; PEDEGO Research Unit, Department of Dermatology, Medical Research Unit, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Worm M; Department of Dermatology, Medical University Sofia, Sofia, Bulgaria.
  • Zillikens D; Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Sadik CD; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • van Beek N; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • König IR; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Schmidt E; Institute of Medical Biometry and Statistics, University of Lübeck, Lübeck, Germany.
J Eur Acad Dermatol Venereol ; 36(11): 2181-2189, 2022 Nov.
Article en En | MEDLINE | ID: mdl-35796163

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad del Suero / Antipsicóticos / Penfigoide Ampolloso / Inhibidores de la Dipeptidil-Peptidasa IV / Insulinas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad del Suero / Antipsicóticos / Penfigoide Ampolloso / Inhibidores de la Dipeptidil-Peptidasa IV / Insulinas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article